NANoREG D6 01

NANoREG D2.08 SOP 08 For hydrochemical reactivity and biodurability testing using an Atmosphere-Temperature-pH-controlled SBR

Acesse:

ttps://www.rivm.nl/en/documenten/nanoreg-d208-sop-08-for-hydrochemical-reactivity-and-biodurability-testing-using

NANoREG D5 02 DR Report on the development of a solubility testing procedure

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-02-dr-report-on-development-of-solubility-testing-procedure 

NANoREG D6.02 DR Inventory of safety assessment issues and new approaches to research and governance

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d602-dr-inventory-of-safety-assessment-issues-and-new-approaches-to-research-and 

NANoREG D1.04 DR NANoREG data platform operational

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d104-dr-nanoreg-data-platform-operational

NANoREG D5 06 DR Identification and optimization of the most suitable in vitro methodology

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d5-06-dr-identification-and-optimization-of-most-suitable-in-vitro-methodology 

SOPs available in deliverable:

• SOP 01 LAL Assay for Nanoparticles
• SOP 02 LDH assay
• SOP 03 Reaction Oxygen Species Detection
• SOP 04 Human Lung Cell transformation assay. Long term chronic experiment
• SOP 05 Apoptosis/Necrosis Analysis
• SOP 06 Production of pro-inflammatory cytokines

NANoREG D1.02 DR Regulatory data gaps and research needs

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d102-dr-regulatory-data-gaps-and-research-needs